Stillwater Capital Advisors LLC lifted its position in UnitedHealth Group Inc (NYSE:UNH) by 1.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 41,033 shares of the healthcare conglomerate’s stock after purchasing an additional 442 shares during the quarter. UnitedHealth Group accounts for approximately 2.7% of Stillwater Capital Advisors LLC’s holdings, making the stock its 13th biggest holding. Stillwater Capital Advisors LLC’s holdings in UnitedHealth Group were worth $12,063,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Johanson Financial Advisors Inc. raised its position in UnitedHealth Group by 28,935.9% in the 4th quarter. Johanson Financial Advisors Inc. now owns 3,384,419 shares of the healthcare conglomerate’s stock valued at $11,512,000 after purchasing an additional 3,372,763 shares during the last quarter. Boston Partners boosted its stake in UnitedHealth Group by 160.8% in the second quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after purchasing an additional 1,572,711 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its stake in UnitedHealth Group by 63.3% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,705,888 shares of the healthcare conglomerate’s stock worth $416,254,000 after purchasing an additional 661,064 shares in the last quarter. Nomura Holdings Inc. grew its holdings in shares of UnitedHealth Group by 474.5% during the third quarter. Nomura Holdings Inc. now owns 561,936 shares of the healthcare conglomerate’s stock worth $122,846,000 after purchasing an additional 464,121 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its holdings in shares of UnitedHealth Group by 29,257.1% during the fourth quarter. Assenagon Asset Management S.A. now owns 440,356 shares of the healthcare conglomerate’s stock worth $129,456,000 after purchasing an additional 438,856 shares during the last quarter. 85.79% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:UNH opened at $300.53 on Wednesday. The company has a current ratio of 0.69, a quick ratio of 0.70 and a debt-to-equity ratio of 0.61. UnitedHealth Group Inc has a 1-year low of $208.07 and a 1-year high of $302.54. The stock has a market capitalization of $282.77 billion, a P/E ratio of 20.97, a P/E/G ratio of 1.46 and a beta of 0.65. The business has a 50-day moving average price of $290.73 and a two-hundred day moving average price of $256.70.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.77 by $0.13. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The company had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. During the same quarter last year, the firm earned $3.28 EPS. The company’s revenue for the quarter was up 4.3% on a year-over-year basis. As a group, equities analysts predict that UnitedHealth Group Inc will post 16.47 EPS for the current year.
In related news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the company’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Corporate insiders own 0.82% of the company’s stock.
A number of research firms recently issued reports on UNH. Credit Suisse Group lifted their price target on UnitedHealth Group from $320.00 to $330.00 and gave the company an “outperform” rating in a report on Wednesday, January 8th. Stephens upped their price target on shares of UnitedHealth Group from $325.00 to $333.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 15th. Wells Fargo & Co reissued an “overweight” rating and set a $335.00 price objective (up previously from $318.00) on shares of UnitedHealth Group in a report on Wednesday, December 11th. Piper Jaffray Companies raised their price objective on shares of UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a research report on Wednesday, December 4th. Finally, Barclays reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Sunday. Five research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $313.50.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.